IQVIA Holdings Inc. IQV

270.37 (4.65) (1.69%) as of 25 Sep
Market cap
$45.3B
P/E
33.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

IQVIA Holdings Inc. (IQV) EV/Sales

As of 25 September 2026, IQVIA Holdings Inc. (IQV) trades at a EV/Sales of 3.5×. Over the past ten years it has ranged from 1.5× (February 2016) to 4.8× (December 2021); the current reading is higher than 58% of that period. That is below the Diagnostics & Research industry median of 5.7× and in line with the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 3.2× 3.47%
FY2024 3.1× (14.78%)
FY2023 3.6× 5.54%
FY2022 3.4× (26.01%)
FY2021 4.7× 17.87%
FY2020 4.0× 7.20%
FY2019 3.7× 13.83%
FY2018 3.2× 1.57%
FY2017 3.2× 24.70%
FY2016 2.6× 47.69%

Quarterly

Period EV/Sales Change
Jun 2026 2.7× 6.16%
Mar 2026 2.6× (20.46%)
Dec 2025 3.2× 12.61%
Sep 2025 2.8× 10.79%
42 more quarters

Against its own ten years

Low 1.5× High 4.8×
Ten-year median 3.4×
Current reading's percentile 58

EV/Sales against peers

Company EV/Sales
DGX Quest Diagnostics Incorporated compare 2.7×
IQV IQVIA Holdings Inc. 3.5×
A Agilent Technologies, Inc. compare 6.9×
MTD Mettler-Toledo International, Inc. compare 7.9×
IDXX IDEXX Laboratories, Inc. compare 9.1×
ILMN Illumina, Inc. compare 9.3×
WAT Waters Corporation compare 10.1×
GH Guardant Health, Inc. compare 20.3×
NTRA Natera, Inc. compare 21.6×
Diagnostics & Research industry median 5.7×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on IQV